Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |